Guangzhou Industrial Investment Capital Management
Overview
Guangzhou Industrial Investment Capital Management is a state-owned investment firm that serves as the core platform for strategic investment and fund management under the Guangzhou Industrial Investment Holding Group.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leadinno Medical Valley | Oct 2025 | Series B | Co-investor |
| Shenzhen Vivolight Medical Device & Technology Co., Ltd. | Mar 2024 | Strategic | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Guangzhou Industrial Investment Capital Management based?
Guangzhou Industrial Investment Capital Management is headquartered in Guangzhou, China.
When was Guangzhou Industrial Investment Capital Management founded?
Guangzhou Industrial Investment Capital Management was founded in 2021.
How many portfolio companies does Guangzhou Industrial Investment Capital Management have?
Guangzhou Industrial Investment Capital Management has 2 portfolio companies in Caplight's dataset.
What are some companies in Guangzhou Industrial Investment Capital Management's portfolio?
Recent investments visible on Caplight include Leadinno Medical Valley, Shenzhen Vivolight Medical Device & Technology Co., Ltd..
What was Guangzhou Industrial Investment Capital Management's most recent investment?
Guangzhou Industrial Investment Capital Management's most recent investment on Caplight was in Leadinno Medical Valley in 2025.
What sectors does Guangzhou Industrial Investment Capital Management focus on?
Guangzhou Industrial Investment Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Guangzhou Industrial Investment Capital Management focus on?
Guangzhou Industrial Investment Capital Management typically invests at the Mid stage.
What is Guangzhou Industrial Investment Capital Management's AUM?
Guangzhou Industrial Investment Capital Management's assets under management are estimated between $4.1B and $17.8B.